GLP1R and obesity due to melanocortin 4 receptor deficiency: It includes a comprehensive summary of current management and referral options for primary care clinicians, a discussion of the most up‐to‐date clinical guidelines for the use of GLP‐1 receptor agonists in England, and the evolving ways in which obesity is identified and defined.